People with Hashimoto's thyroiditis. Autoimmune thyroiditis
Conditions
Interventions
Intervention 1: Intervention group: Global Quality Diet (GDQS): In this group, people with Hashimoto's are trained on the GDQS diet for 2 sessions (the first week after the intervention and the last w
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Written informed consent from patients BMI higher than 18.5 Age range 18 to 65 years Patients with Hashimoto's euthyroidism and subclinical hypothyroidism (based on blood levels of TPO-Ab, TSH, FT4)
Exclusion criteria
Exclusion criteria: history of bariatric or malabsorptive surgery until one year before the start of the study History of weight loss and slimming surgeries up to one year before the start of the study Pregnant and breastfeeding women use of anti-inflammatory drugs and corticosteroids, thyroid hormone medications, antithyroid drugs, oral glucocorticoids, lithium, amiodarone, and biotin specific diet regimen until three months before the start of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anti-TPO Ab level. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Standard ELISA/RIA Kit by reference laboratory.;TSH level. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Standard ELISA/RIA Kit by reference laboratory.;FT4 level. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Standard ELISA/RIA Kit by reference laboratory.;FT3 level. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Standard ELISA/RIA Kit by reference laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Scales.;Waist circumference. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Meter.;Hip circumference. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Meter.;Body mass index. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Weight / (height)^?.;Blood pressure. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: Digital Sphygmomanometer.;Sleep quality score. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: PSQI Sleep Quality Questionnaire.;Quality of life score. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: ThyPRO39 Quality of Life Questionnaire.;Physical activity score. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: IPAQ Physical Activity Questionnaire.;Socioeconomic status score. Timepoint: At the beginning of the intervention and 12 weeks after the start of the intervention. Method of measurement: SES questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactnesa maleki moghadam nezhad
Yazd University of Medical Sciences
Outcome results
None listed